The Food and Drug Administration has expanded the use of Roche subsidiary Genentech's advanced lung cancer drug Tarceva erlotinib. Tarceva is now the first personalised medicine approved for patients…
Adaptive Biotechnologies a Seattlebased developer of next generation sequencing assays has entered into a collaboration agreement with BristolMyers Squibb for the discovery of immunological biomarkers…
HOUSTON May 15 2013 PRNewswire &160;ApoCell Inc. announced that the first prototypes of its ApoStream&8482; circulating tumor cell CTC isolation system have been delivered to select investigat…
Will use immune assay to identify biomarkers in cells of cancer patients…
